Citadel Advisors’s Gyre Therapeutics GYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $23.1K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $3.28K | Sell |
|
|||||
|
2022
Q4 | $164K | Buy |
|
|||||
|
2022
Q3 | $31K | Sell |
|
|||||
|
2022
Q2 | $135K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $29K | Sell |
|
|||||
|
2021
Q3 | $268K | Buy |
|
|||||
|
2021
Q2 | – | Hold |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $280K | Buy |
|
|||||
|
2020
Q3 | $133K | Sell |
|
|||||
|
2020
Q2 | $2.43M | Sell |
|
|||||
|
2020
Q1 | $2.71M | Buy |
|
|||||
|
2019
Q4 | $2.56M | Buy |
|
|||||
|
2019
Q3 | $1.45M | Buy |
|
|||||
|
2019
Q2 | $402K | Buy |
|
|||||
|
2019
Q1 | $412K | Sell |
|
|||||
|
2018
Q4 | $588K | Buy |
|
|||||
|
2018
Q3 | $472K | Buy |
|
|||||
|
2018
Q2 | $168K | Buy |
|
|||||
|
2018
Q1 | – | Hold |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $16K | Buy |
|
|||||
|
2016
Q3 | $22K | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $41K | Sell |
|
|||||
|
2014
Q4 | $44K | Buy |
|
|||||
|
2014
Q3 | $20K | Buy |
|
|||||
|
2014
Q2 | $15K | Buy |
|
|||||
|
2014
Q1 | – | Sell |
|
|||||
|
2013
Q4 | $12K | Hold |
|
|||||
|
2013
Q3 | $15K | Sell |
|
|||||
|
2013
Q2 | $35K | Buy |
|